The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended approval of the macrocyclic, high-relaxivity Vueway® (Gadopiclenol) in adults and pediatric patients older than 2 years of age. MILAN, Oct. 13, 2023 /PRNewswire/ — Bracco Imaging…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.